Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $1.59 USD
Change Today -0.10 / -5.92%
Volume 215.4K
BGMD On Other Exchanges
As of 5:20 PM 08/4/15 All times are local (Market data is delayed by at least 15 minutes).

bg medicine inc (BGMD) Snapshot

Previous Close
Day High
Day Low
52 Week High
01/30/15 - $4.88
52 Week Low
12/15/14 - $1.08
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for BG MEDICINE INC (BGMD)

bg medicine inc (BGMD) Related Businessweek News

No Related Businessweek News Found

bg medicine inc (BGMD) Details

BG Medicine, Inc., a commercial stage company, engages in developing and commercializing diagnostic products used to guide the patients suffering from heart failure and related disorders. The company offers BGM Galectin-3 Test, an in vitro diagnostic device that measures galectin-3 in serum or plasma by enzyme linked immunosorbent assay on a microtiter plate platform; and CardioSCORE Test, a multi-analyte biomarker-based blood test used for the assessment of near-term risk of atherothrombotic cardiovascular events, such as heart attack and ischemic stroke. It has license, development, and commercialization agreements with Abbott Laboratories, bioMérieux SA, Siemens Healthcare Diagnostics Inc., and Alere Inc. for the automated instrument versions of galectin-3 test; and a strategic collaboration with Abbott Laboratories to develop and commercialize galectin-3 assay kits, and related control kits and calibrators. The company was formerly known as Beyond Genomics, Inc. and changed its name to BG Medicine, Inc. in October 2004. BG Medicine, Inc. was founded in 2000 and is headquartered in Waltham, Massachusetts.

7 Employees
Last Reported Date: 03/31/15
Founded in 2000

bg medicine inc (BGMD) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $400.0K
Chief Financial Officer, Principal Accounting...
Total Annual Compensation: $290.0K
Chief Scientific Officer and Senior Vice Pres...
Total Annual Compensation: $275.0K
Compensation as of Fiscal Year 2014.

bg medicine inc (BGMD) Key Developments

BG Medicine, Inc. Announces Payoff of Secured Term Loan

BG Medicine, Inc. announced that it has paid off its secured term loan facility with General Electric Capital Corporation and Comerica Bank. The secured term loan in the aggregate principal amount of $10 million was funded to BG Medicine in February 2012. BG Medicine has been making monthly principal and interest payments on this loan since August 2013. With payoff, all security interests that had been granted to the secured lenders are now released and discharged.

BG Medicine, Inc. Announces Amendment to the Certificate of Incorporation

BG Medicine, Inc. announced that at the AGM held on July 7, 2015, the shareholders approved amendment to the company's restated certificate of incorporation to effect a reverse stock split of the Company's common stock.

BG Medicine, Inc. Announces First Automated Test for Galectin-3 Now Available in U.S

BG Medicine, Inc. announced that the ARCHITECT® Galectin-3 assay is now available. This automated blood test was cleared by the United States Food and Drug Administration (FDA) for use in conjunction with clinical evaluation as an aid in assessing the prognosis of patients diagnosed with chronic heart failure. The ARCHITECT Galectin-3 assay is performed using the Abbott ARCHITECT automated immunoassay analyzer and is being commercialized through an agreement between BG Medicine and Abbott.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BGMD:US $1.59 USD -0.10

BGMD Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Alere Inc $52.68 USD +2.59
Bio-Reference Laboratories Inc $43.95 USD -0.32
BioMerieux €107.70 EUR +0.45
Laboratory Corp of America Holdings $127.01 USD -0.34
Quest Diagnostics Inc $74.58 USD +0.38
View Industry Companies

Industry Analysis


Industry Average

Valuation BGMD Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 5.9x
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales 4.5x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BG MEDICINE INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at